Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Armand

Showing results (41-50 of 273) with videos related to

Pageof 28
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|March 12, 2014
Crizotinib as salvage and maintenance with allogeneic stem cell transplantation for refractory anaplastic large cell lymphomaJames M Cleary, Scott Rodig, Paul M Barr, et al.
Journal of Medical Economics|March 31, 2021
Treatment patterns, healthcare resource utilization, and costs of patients diagnosed with primary mediastinal B-cell lymphoma in the United StatesXiaoqin Yang, François Laliberté, Guillaume Germain, et al.
The Oncologist|February 22, 2021
Real-World Characteristics, Treatment Patterns, Health Care Resource Use, and Costs of Patients with Diffuse Large B-Cell Lymphoma in the U.SXiaoqin Yang, François Laliberté, Guillaume Germain, et al.
Blood Advances|June 20, 2020
KEYNOTE-013 4-year follow-up of pembrolizumab in classical Hodgkin lymphoma after brentuximab vedotin failurePhilippe Armand, John Kuruvilla, Jean-Marie Michot, et al.
Blood|August 31, 2016
Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapyBruce D Cheson, Stephen Ansell, Larry Schwartz, et al.
Blood|January 20, 2007
Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantationPhilippe Armand, Haesook T Kim, Corey S Cutler, et al.
The New England Journal of Medicine|June 12, 2024
Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell TherapyMetin Ozdemirli, Thomas M Loughney, Emre Deniz, et al.
Haematologica|June 30, 2016
Donor and recipient sex in allogeneic stem cell transplantation: what really mattersHaesook T Kim, Mei-Jie Zhang, Ann E Woolfrey, et al.
Blood|March 31, 2017
PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphomaLakshmi Nayak, Fabio M Iwamoto, Ann LaCasce, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 6, 2017
High-dose Thiotepa, Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplantation as Upfront Consolidation for Systemic Non-Hodgkin Lymphoma With Synchronous Central Nervous System InvolvementDavid Qualls, Andrew Sullivan, Shuli Li, et al.
Pageof 28

Showing results (41-50 of 273) with videos related to

Sort By:
Pageof 28
Journal of the National Comprehensive Cancer Network : JNCCN|March 12, 2014
Crizotinib as salvage and maintenance with allogeneic stem cell transplantation for refractory anaplastic large cell lymphomaJames M Cleary, Scott Rodig, Paul M Barr, et al.
Journal of Medical Economics|March 31, 2021
Treatment patterns, healthcare resource utilization, and costs of patients diagnosed with primary mediastinal B-cell lymphoma in the United StatesXiaoqin Yang, François Laliberté, Guillaume Germain, et al.
The Oncologist|February 22, 2021
Real-World Characteristics, Treatment Patterns, Health Care Resource Use, and Costs of Patients with Diffuse Large B-Cell Lymphoma in the U.SXiaoqin Yang, François Laliberté, Guillaume Germain, et al.
Blood Advances|June 20, 2020
KEYNOTE-013 4-year follow-up of pembrolizumab in classical Hodgkin lymphoma after brentuximab vedotin failurePhilippe Armand, John Kuruvilla, Jean-Marie Michot, et al.
Blood|August 31, 2016
Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapyBruce D Cheson, Stephen Ansell, Larry Schwartz, et al.
Blood|January 20, 2007
Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantationPhilippe Armand, Haesook T Kim, Corey S Cutler, et al.
The New England Journal of Medicine|June 12, 2024
Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell TherapyMetin Ozdemirli, Thomas M Loughney, Emre Deniz, et al.
Haematologica|June 30, 2016
Donor and recipient sex in allogeneic stem cell transplantation: what really mattersHaesook T Kim, Mei-Jie Zhang, Ann E Woolfrey, et al.
Blood|March 31, 2017
PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphomaLakshmi Nayak, Fabio M Iwamoto, Ann LaCasce, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 6, 2017
High-dose Thiotepa, Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplantation as Upfront Consolidation for Systemic Non-Hodgkin Lymphoma With Synchronous Central Nervous System InvolvementDavid Qualls, Andrew Sullivan, Shuli Li, et al.
Pageof 28